-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
MetLife Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$67.84 B | $63.65 B | $67.82 B | $66.41 B | $69.90 B |
| Cost of Revenue |
|
- | - | - | $494.00 M | -$1.09 B |
| Gross Profit |
|
$67.84 B | $63.65 B | $67.82 B | $65.91 B | $70.99 B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
$5.78 B | $5.77 B | $5.89 B | $6.18 B | $5.99 B |
| Operating Expense |
|
$59.84 B | $55.14 B | $61.46 B | $64.25 B | $64.28 B |
| Operating Income |
|
$6.93 B | $8.52 B | $6.36 B | $2.16 B | $5.62 B |
| Net Income |
|
$5.41 B | $6.86 B | $5.28 B | $1.58 B | $4.43 B |
MetLife Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$378.51 B | $367.50 B | $301.91 B | $302.05 B | $100.57 B |
| Inventories |
|
- | - | - | - | - |
| Total Current Assets |
|
$396.38 B | $384.83 B | $296.98 B | $302.05 B | $131.34 B |
| Property,Plant and Equipment |
|
- | - | - | - | $1.85 B |
| Goodwill |
|
$10.11 B | $9.54 B | $9.30 B | $9.24 B | $8.90 B |
| Total Assets |
|
$795.15 B | $759.71 B | $663.07 B | $687.58 B | $677.46 B |
| Total Liabilities |
|
$720.33 B | $691.96 B | $632.95 B | $657.33 B | $649.75 B |
| Retained Earnings |
|
$36.49 B | $41.20 B | $40.33 B | $40.15 B | $42.63 B |
| Total Shareholder Equity |
|
$74.56 B | $67.48 B | $29.88 B | $30.02 B | $27.45 B |
| Common Stock |
|
$12.00 M | $12.00 M | $12.00 M | $12.00 M | $12.00 M |
MetLife Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$619.00 M | $694.00 M | $673.00 M | $718.00 M | $714.00 M |
| Dividends Payout |
|
-$1.86 B | -$1.84 B | -$1.78 B | -$1.76 B | -$1.73 B |
| Capital Expenditures (Capex) |
|
- | $4.36 B | - | -$1.17 B | - |
| Free Cash Flow (FCF) |
|
$11.64 B | $12.35 B | $13.04 B | $13.72 B | $14.60 B |
MetLife Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$67.84 B | $63.65 B | $67.82 B | $65.91 B | $70.99 B |
| Gross Profit Margin (%) |
|
100.00% | 100.00% | 100.00% | 99.26% | 101.56% |
| Operating Income |
|
$6.93 B | $8.52 B | $6.36 B | $2.16 B | $5.62 B |
| Operating Income Margin (%) |
|
10.21% | 13.38% | 9.38% | 3.26% | 8.04% |
| Net Income |
|
$5.41 B | $6.86 B | $5.28 B | $1.58 B | $4.43 B |
| Net Income Margin (%) |
|
7.97% | 10.77% | 7.79% | 2.38% | 6.33% |
| EBITDA |
|
$8.46 B | $9.74 B | $7.98 B | $3.93 B | $7.37 B |
| EBITDA Margin (%) |
|
12.47% | 15.30% | 11.76% | 5.91% | 10.55% |
MetLife Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
7.25% | 10.16% | 17.68% | 5.26% | 16.13% |
| Return on Assets (ROA) |
|
0.68% | 0.90% | 0.80% | 0.23% | 0.65% |
| Debt to Equity |
|
24.34% | 25.83% | 60.17% | 62.73% | 4.25% |
| Debt to total asset |
|
2.28% | 2.29% | 2.71% | 2.74% | 0.17% |
| Enterprise value to revenue |
|
0.63 | 0.77 | 0.80 | 0.73 | 0.56 |
| Enterprise value to EBITDA |
|
5.09 | 5.03 | 6.79 | 12.38 | 5.28 |
| Enterprise value |
|
$43.05 B | $48.97 B | $54.17 B | $48.61 B | $38.94 B |
| Cash to Debt |
|
64.13% | 70.84% | 72.55% | 72.88% | 1,250.90% |
| Tax Rate (%) |
|
21.78% | 19.09% | 16.69% | 25.90% | 20.95% |
| Payout Ratio |
|
34.38% | 26.87% | 33.74% | 111.79% | 39.02% |
